BW Offshore
22.2.2021 21:01:36 CET | Globenewswire | Press release
Mandatory notification of trade
Marco Beenen, CEO of BW Offshore, has settled a Total Return Swap ("TRS") agreement underlying 50,000 shares in BW Offshore Limited ("BWO") expiring 22 February 2021. Mr Beenen has subsequently entered into a new TRS agreement with exposure to the same number of underlying shares in BWO with expiry date 25 August 2021 and TRS price NOK 37.47 per underlying share. In addition, Mr. Beenen owns 46,692 shares in BWO, as previously disclosed.
Ståle Andreassen, CFO of BW Offshore, has settled a Total Return Swap ("TRS") agreement underlying 30,000 shares in BW Offshore Limited ("BWO") expiring 22 February 2021. Mr Andreassen has subsequently entered into a new TRS agreement with exposure to the same number of underlying shares in BWO with expiry date 25 August 2021 and TRS price NOK 37.47 per underlying share. In addition, Mr. Andreassen owns 229,273 shares in BWO, as previously disclosed.
For further information, please contact:
Ståle Andreassen, CFO, +65 97 27 86 47
Anders S. Platou, Head of Corporate Finance, +47 99 50 47 40
IR@bwoffshore.com or www.bwoffshore.com
About BW Offshore:
BW Offshore engineers innovative floating production solutions. The Company has a fleet of 15 FPSOs with potential and ambition to grow. By leveraging four decades of offshore operations and project execution, the Company creates tailored energy solutions for evolving markets world-wide. BW Offshore has around 2,000 employees and is publicly listed on the Oslo Stock Exchange.
This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
King Faisal Specialist Hospital & Research Centre13.3.2026 22:15:53 CET | Press release
KFSH Leads Globally in Paired Kidney Transplants Performed at a Single Center in 2025
SCOR13.3.2026 18:59:39 CET | Press release
SCOR SE announces the availability of its 2025 Universal Registration Document
Novartis Pharma AG13.3.2026 18:35:19 CET | Press release
Novartis Cosentyx® receives FDA approval for pediatric patients aged 12+ with moderate to severe hidradenitis suppurativa
Luotea Oyj13.3.2026 18:30:00 CET | Press release
The Board of Directors of Luotea Oyj decided on updates to the company's share-based incentive plan for 2023-2027 and on the launch of a new share-based incentive plan for the years 2026-2030
Ilkka Oyj13.3.2026 18:00:00 CET | Press release
Ilkka Oyj: Acquisition of own shares on 13 March 2026
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
